Hormone resistance and short stature: A journey through the pathways of hormone signaling

Nenhuma Miniatura disponível
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2021
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER IRELAND LTD
Citação
MOLECULAR AND CELLULAR ENDOCRINOLOGY, v.536, article ID 111416, 12p, 2021
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Hormone resistances have been described in association with growth disorders, the majority involving the growth hormone (GH)/insulin-like growth factor 1(IGF-1) axis or hormones with specific paracrine-autocrine actions in the growth plate. Defects in hormone receptors or in proteins involved in intracellular signal transduction (post-receptor defects) are the main mechanisms of hormone resistance leading to short stature. The characteristic phenotypes of each of these hormonal resistances are very distinct and bring with them important insights into the role of each hormone and its signaling pathway. In this review, we discuss the molecular and clinical aspects of the main hormone resistances associated with short stature in humans.
Palavras-chave
Growth hormone, IGF-1, Growth plate, Growth hormone deficiency, Growth hormone insensitivity, IGF insensitivity, Natriuretic peptide system
Referências
  1. Abuzzahab MJ, 2003, NEW ENGL J MED, V349, P2211, DOI 10.1056/NEJMoa010107
  2. Aguiar-Oliveira MH, 2019, ENDOCR REV, V40, P575, DOI 10.1210/er.2018-00216
  3. Alatzoglou KS, 2014, ENDOCR REV, V35, P376, DOI 10.1210/er.2013-1067
  4. Albarran-Zeckler RG, 2013, ENDOCR DEV, V25, P5, DOI 10.1159/000346042
  5. [Anonymous], 2016, EUR J ENDOCRINOL, DOI 10.1530/EJE-16-0107
  6. Arya VB, 2020, HORM RES PAEDIAT, V93, P335, DOI 10.1159/000511874
  7. Avila M, 2016, CLIN GENET, V89, P501, DOI 10.1111/cge.12688
  8. Ayling RM, 1997, NAT GENET, V16, P13, DOI 10.1038/ng0597-13
  9. BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O
  10. Bartels CF, 2004, AM J HUM GENET, V75, P27, DOI 10.1086/422013
  11. Blum WF, 2018, EBIOMEDICINE, V36, P390, DOI 10.1016/j.ebiom.2018.09.026
  12. BORRELLI P, 1983, PEDIATR RADIOL, V13, P165, DOI 10.1007/BF01624409
  13. Cannata Dara, 2010, Adv Pediatr, V57, P331, DOI 10.1016/j.yapd.2010.09.003
  14. Chikuda H, 2004, GENE DEV, V18, P2418, DOI 10.1101/gad.1224204
  15. Chudasama KK, 2013, AM J HUM GENET, V93, P150, DOI 10.1016/j.ajhg.2013.05.023
  16. Chusho H, 2001, P NATL ACAD SCI USA, V98, P4016, DOI 10.1073/pnas.071389098
  17. Collett-Solberg PF, 2019, GROWTH HORM IGF RES, V44, P20, DOI 10.1016/j.ghir.2018.12.004
  18. Corazzini V, 2013, ENDOCR DEV, V24, P106, DOI 10.1159/000342575
  19. David A, 2011, ENDOCR REV, V32, P472, DOI 10.1210/er.2010-0023
  20. Domene S, 2020, MOL CELL ENDOCRINOL, V518, DOI 10.1016/j.mce.2020.111006
  21. Dyment DA, 2013, AM J HUM GENET, V93, P158, DOI 10.1016/j.ajhg.2013.06.005
  22. Ester WA, 2009, J CLIN ENDOCR METAB, V94, P4717, DOI 10.1210/jc.2008-1502
  23. Forbes BE, 2020, MOL CELL ENDOCRINOL, V518, DOI 10.1016/j.mce.2020.111035
  24. Freire BL, 2019, J CLIN ENDOCR METAB, V104, P2023, DOI 10.1210/jc.2018-01971
  25. Fujimoto M, 2020, MOL CELL ENDOCRINOL, V518, DOI 10.1016/j.mce.2020.110967
  26. Giabicani E, 2020, J MED GENET, V57, P160, DOI 10.1136/jmedgenet-2019-106328
  27. GODOWSKI PJ, 1989, P NATL ACAD SCI USA, V86, P8083, DOI 10.1073/pnas.86.20.8083
  28. Guevara-Aguirre J, 2021, REV ENDOCR METAB DIS, V22, P59, DOI 10.1007/s11154-020-09602-4
  29. Guevara-Aguirre J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001845
  30. Hachiya R, 2007, J CLIN ENDOCR METAB, V92, P4009, DOI 10.1210/jc.2007-1101
  31. Hauer NN, 2018, GENET MED, V20, P630, DOI 10.1038/gim.2017.159
  32. Heath K.E, 2020, J MED GENET
  33. Hisado-Oliva A, 2015, J CLIN ENDOCR METAB, V100, pE1133, DOI 10.1210/jc.2015-1612
  34. Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298
  35. Hume AN, 2009, HUM MOL GENET, V18, P267, DOI 10.1093/hmg/ddn354
  36. Hwa V, 2004, J BIOL CHEM, V279, P2728, DOI 10.1074/jbc.M310495200
  37. Hwa V, 2021, MOL CELL ENDOCRINOL, V519, DOI 10.1016/j.mce.2020.111063
  38. Iida K, 1999, J CLIN ENDOCR METAB, V84, P1011, DOI 10.1210/jc.84.3.1011
  39. Innes A.M., 1993, GENEREVIEWS R
  40. Inoue H, 2011, CLIN ENDOCRINOL, V74, P223, DOI 10.1111/j.1365-2265.2010.03911.x
  41. Kaiya H, 2014, J MOL ENDOCRINOL, V52, pT87, DOI 10.1530/JME-13-0175
  42. Khan S, 2016, EUR J MED GENET, V59, P198, DOI 10.1016/j.ejmg.2016.02.011
  43. Klammt J, 2011, BEST PRACT RES CL EN, V25, P191, DOI 10.1016/j.beem.2010.09.012
  44. Klammt J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04521-0
  45. Kofoed EM, 2003, NEW ENGL J MED, V349, P1139, DOI 10.1056/NEJMoa022926
  46. LANGER LO, 1980, RADIOLOGY, V137, P349, DOI 10.1148/radiology.137.2.7433666
  47. Laron Z, 2004, J CLIN ENDOCR METAB, V89, P1031, DOI 10.1210/jc.2003-031033
  48. Legare J.M., 1993, GENEREVIEWS R
  49. LIN SC, 1993, NATURE, V364, P208, DOI 10.1038/364208a0
  50. Lin-Su Karen, 2002, Rev Endocr Metab Disord, V3, P313, DOI 10.1023/A:1020949507265
  51. LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K
  52. Majri SS, 2018, J IMMUNOL, V200, P110, DOI 10.4049/jimmunol.1701133
  53. Malaquias AC, 2021, MOL CELL ENDOCRINOL, V519, DOI 10.1016/j.mce.2020.111040
  54. MAROTEAUX P, 1971, PRESSE MED, V79, P1839
  55. Marui S, 2012, HORM RES PAEDIAT, V78, P165, DOI 10.1159/000342760
  56. Masunaga Y, 2021, ENDOCR J, V68, P111, DOI 10.1507/endocrj.EJ20-0291
  57. Nakaguma M, 2019, ENDOCR CONNECT, V8, P590, DOI 10.1530/EC-19-0085
  58. OGAWA Y, 1994, GENOMICS, V24, P383, DOI 10.1006/geno.1994.1633
  59. Olney RC, 2006, J CLIN ENDOCR METAB, V91, P1229, DOI 10.1210/jc.2005-1949
  60. Osorio MGF, 2002, J CLIN ENDOCR METAB, V87, P5076, DOI 10.1210/jc.2001-011936
  61. Ozasa A, 2005, BONE, V36, P1056, DOI 10.1016/j.bone.2005.03.006
  62. Pereira RMC, 2007, J CLIN ENDOCR METAB, V92, P2353, DOI 10.1210/jc.2007-0092
  63. Pfeifer A, 1996, SCIENCE, V274, P2082, DOI 10.1126/science.274.5295.2082
  64. Prontera P, 2015, HUM MUTAT, V36, P1043, DOI 10.1002/humu.22853
  65. Salvatori R, 1999, J CLIN ENDOCR METAB, V84, P917, DOI 10.1210/jc.84.3.917
  66. Salvatori R, 2002, MOL ENDOCRINOL, V16, P450, DOI 10.1210/me.16.3.450
  67. Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]
  68. Scalco RC, 2015, EUR J ENDOCRINOL, V173, P291, DOI 10.1530/EJE-15-0398
  69. Schulz S, 2005, PEPTIDES, V26, P1024, DOI 10.1016/j.peptides.2004.08.027
  70. Shapiro L, 2017, EUR J ENDOCRINOL, V177, P485, DOI 10.1530/EJE-17-0453
  71. Storr HL, 2019, ENDOCR REV, V40, P476, DOI 10.1210/er.2018-00146
  72. SUGA SI, 1992, ENDOCRINOLOGY, V130, P229, DOI 10.1210/en.130.1.229
  73. Tamura N, 2004, P NATL ACAD SCI USA, V101, P17300, DOI 10.1073/pnas.0407894101
  74. Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0
  75. Thauvin-Robinet C, 2013, AM J HUM GENET, V93, P141, DOI 10.1016/j.ajhg.2013.05.019
  76. van Gucht ALM, 2017, CURR TOP DEV BIOL, V125, P337, DOI 10.1016/bs.ctdb.2017.02.001
  77. Vasques GA, 2014, HORM RES PAEDIAT, V82, P222, DOI 10.1159/000365049
  78. Vasques GA, 2013, J CLIN ENDOCR METAB, V98, pE1636, DOI 10.1210/jc.2013-2142
  79. Wajnrajch MP, 1996, NAT GENET, V12, P88, DOI 10.1038/ng0196-88
  80. Wajnrajch MP, 2003, AM J MED GENET A, V120A, P77, DOI 10.1002/ajmg.a.10209
  81. Walenkamp MJE, 2019, J CLIN ENDOCR METAB, V104, P3157, DOI 10.1210/jc.2018-02065
  82. Wang J, 2004, J ENDOCRINOL, V180, P247, DOI 10.1677/joe.0.1800247
  83. Wang SR, 2015, HUM MUTAT, V36, P474, DOI 10.1002/humu.22773
  84. Waters MJ, 2011, HORM RES PAEDIAT, V76, P12, DOI 10.1159/000329138
  85. Wit JM, 2021, HORM RES PAEDIAT, DOI 10.1159/000516407
  86. Woods KA, 1997, J CLIN ENDOCR METAB, V82, P3529, DOI 10.1210/jc.82.11.3529
  87. Yasoda A, 1998, J BIOL CHEM, V273, P11695, DOI 10.1074/jbc.273.19.11695
  88. Zhou FL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18945-0